ACADACADIA Pharmaceuticals Inc.

$27.58

What is the market doing?

What the tape says about ACAD

ACADIA Pharmaceuticals Inc. is +10% over the past year while the S&P 500 is +20%: 10 points behind the market.

+10%

1-year return · S&P 500 +20%

vs 200-day average
+14%

vs 200-day average · a clear uptrend

RSI (14)
40

RSI (14) · neutral

Below its 52-week high
9.8%

Below its 52-week high

2024-08-15$14.10 – $30.58 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$27.58
1 monthS&P 500 −0.30%
−3.1%
1 yearS&P 500 +20%
+10%
5 yearsS&P 500 +85%
+50%
vs 50-day average$26.30
+4.9%
52-week high
$30.57
52-week low
$20.06
Annualised volatility
44%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$1.1M
Calendar-year price return
YearReturn
2026 (year to date)+3.2%
2025+46%
2024−41%
2023+97%
2022−32%
2021−56%
2020+25%
2019+165%
2018−46%
2017+4.4%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10+3.8%
Feb107 of 10+3.3%
Mar101 of 10−13%
Apr103 of 10−7.8%
May105 of 10+3.3%
Jun106 of 10+1.7%
Jul117 of 11+4.5%
Aug115 of 11+0.08%
Sep114 of 11+2.4%
Oct105 of 10+0.56%
Nov106 of 10+5.4%
Dec106 of 10+6.3%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.